The authorization by the FDA for digital pathology in the US, the world’s largest healthcare market, constitutes a watershed moment for the healthcare industry.”
Russ Granzow, General Manager,
Philips Digital Pathology Solutions
Hospitals will have an easier path to realizing a return on investment from their use of a digital pathology system, because pathologists can now charge and get reimbursed.”
The ultimate aim of digitization is that all sorts of algorithms – such as image analysis to aid the pathologist in making better and faster decisions – will be developed and become clinically available. Ultimately, this will create even more opportunities for digital innovation – using artificial intelligence for computational pathology and other innovative technologies – that could support increased accuracies, predictive health management or ultimately potentially improve patient outcomes.
Digitizing pathology is indeed taking a giant leap forward and the FDA authorization truly constitutes a watershed moment for the healthcare industry. This achievement reinforces Philips’ leadership in digital pathology, a solution that is central to the diagnosis of complex diseases such as cancer. Now healthcare can reap all the benefits that result when images are digitized, giving clinicians the tools they need to be more effective in this new world of healthcare and making critical health information available faster to healthcare providers and patients.
[1] The Royal College of Pathologists
[2] World Health Organization – Cancer Fact Sheet 2017 and World Cancer Report 2014
Innovation Matters delivers news, opinions and features about healthcare, and is focused on the professionals who work within the industry, as well as Philips as a cutting-edge health technology organization. From interviews with industry giants to how-to guides and features powered by Philips data, our goal is to deliver interesting, educational and entertaining content to empower and inspire all those who work in healthcare or related industries.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.
I understandYou are about to visit a Philips global content page
You are about to visit the Philips USA website.
General Manager, Philips Digital Pathology Solutions
Graduated in Biochemistry. Has a strong track record in deal making, acquisitions and the creation of strategic partnerships in the areas of life science, diagnostics, pharmaceuticals and consumer health. Has significant start up experience, but has also worked with multinationals and as a VC.
Bağlantıya tıklayarak resmi Philips Electronics Ltd. ("Philips") web sitesinden ayrılacaksınız. Bu sitede görülebilecek üçüncü şahıs web sitelerine bağlantılar yalnızca size kolaylık sağlamak amacıyla verilmiştir ve hiçbir şekilde bu bağlantı verilen web sitelerinde sağlanan bilgilerin herhangi bir bağlantısı veya onayını temsil etmez. Philips, herhangi bir üçüncü taraf web sitesi veya burada yer alan bilgilerle ilgili olarak hiçbir beyanda bulunmaz veya garanti vermez.
I understandYou are about to visit a Philips global content page
You are about to visit the Philips USA website.
Sitemiz Microsoft Edge, Google Chrome veya Firefox'un en son sürümüyle en iyi şekilde görüntülenebilir.